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ABSTRACT
The c-myb promoter contains multiple GGA repeats
beginning 17bp downstream of the transcription
initiation site. GGA repeats have been previously
shown to form unusual DNA structures in solution.
Results from chemical footprinting, circular dichro-
ism and RNA and DNA polymerase arrest assays on
oligonucleotides representingtheGGArepeat region
of the c-myb promoter demonstrate that the element
is able to form tetrad:heptad:heptad:tetrad (T:H:H:T)
G-quadruplex structures by stacking two tetrad:hep-
tad G-quadruplexes formed by two of the three
(GGA)4 repeats. Deletion of one or two (GGA)4
motifs destabilizes this secondary structure and
increases c-myb promoter activity, indicating that
the G-quadruplexes formed in the c-myb GGA repeat
region may act as a negative regulator of the c-myb
promoter. Complete deletion of the c-myb GGA
repeat region abolishes c-myb promoter activity,
indicating dual roles of the c-myb GGA repeat
element as both a transcriptional repressor and an
activator. Furthermore, we demonstrated that
Myc-associated zinc finger protein (MAZ) represses
c-myb promoter activity and binds to the c-myb
T:H:H:T G-quadruplexes. Our findings show that the
T:H:H:T G-quadruplex-forming region in the c-myb
promoter is a critical cis-acting element and may
repress c-myb promoter activity through MAZ inter-
action with G-quadruplexes in the c-myb promoter.
INTRODUCTION
The c-myb proto-oncogene, the cellular homologue of the
transforming v-myb oncogene of avian leukemia viruses,
encodes a critical transcription factor for proliferation,
diﬀerentiation and survival of haematopoietic progenitor
cells (1). High levels of the gene product c-Myb prevent
haematopoietic stem cells from both diﬀerentiation and
apoptosis (2,3). Because of the critical role of c-Myb in
determining cell fate, c-Myb expression levels are tightly
controlled in normal cells, showing high levels in
immature, proliferating haematopoietic cells and unde-
tectable levels in diﬀerentiated cells (4). c-Myb is over
expressed in many leukemias and some solid tumors, and
plays a critical role in leukemogenesis by maintaining cells
in a proliferative state and by preventing terminal
diﬀerentiation (5–7). Luger and coworkers showed that
an antisense oligonucleotide (ODN) against c-myb
mRNA could eliminate leukemia cells as a bone marrow
purging agent, resulting in cytogenetic remissions in CML
and showing that c-myb is a potential therapeutic target
for leukemia treatment (8).
Cellular levels of c-myb are regulated at the transcrip-
tional level by several mechanisms. One important
mechanism is blocking mRNA elongation in intron I,
which attenuates c-myb mRNA elongation in a cell type–
dependent manner (9–12). c-Myb transcription is also
controlled by a number of transcription factors. For
example, c-Myb acts as a negative regulator of its own
expression in a lineage-dependent manner (13). WT1
(Wilms Tumor 1), MZF1 (myeloid zinc ﬁnger 1) and PU.1
also down regulate c-myb promoter activity, and the Ets
and c-Jun/JunD transcription factors activate the c-myb
promoter in a lineage-speciﬁc manner (Figure 1A) (14–18).
The c-myb promoter contains a purine-rich region with
three copies of four GGA repeats, [3(GGA)4], located 17
bps downstream of the transcription initiation site on
the bottom strand, and the GGA repeat region is highly
conserved in mammals. Nuclear magnetic resonance
(NMR) and molecular modeling studies showed that
(GGA)4 DNA sequences similar to those found in the
human c-myb promoter can form an unusual secondary
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and composed of a guanine tetrad (T) stacked onto a
guanine-adenine heptad (H) (Figure 1B) (19,20). This
unique G-quadruplex was the ﬁrst identiﬁed
G-quadruplex structure with pseudo-double chain reversal
loops in which the loop base (A) is part of the heptad.
DNA sequences with two adjacent (GGA)4 units,
(GGA)8, can form a very stable (Tm=868C) higher
ordered structure by intramolecularly stacking two T:H
G-quadruplexes on the heptad plane, resulting in a
tetrad:heptad:heptad:tetrad (T:H:H:T) DNA structure
(Figure 1B) (21,22). These structures form in the presence
of physiologic concentrations of potassium ions and at
neutral pH.
GGA repeats found in some promoters are shown to be
a critical cis element for protein:DNA interaction. The
eight GGA repeats (GGA)8 found in the avian SPARC
promoter were shown to be a critical positive regulatory
region with multiple Sp1/Sp3 binding sites (23). In
addition, the human homologue of SPARC, the BM-40
gene, also contains GGA repeats and the region is
required to exert promoter activity of the BM-40 gene
(24). These studies show that GGA repeats in
gene promoters can play critical roles in regulating gene
expression, and suggest that the formation of secondary
DNA structures may be important to the function of cis-
acting GGA repeats.
In the present study we investigated if the c-myb GGA
repeat region can form T:H:H:T G-quadruplexes and if the
regionisacriticalregulatorofpromoteractivity.Wereport
that the c-myb GGA repeat region forms T:H:H:T
G-quadruplexes involving two (GGA)4 regions and acts
asarepressorelementofthec-mybpromoter.However,the
GGA repeat region is also essential for basal promoter
activity of the c-myb gene. We identiﬁed a transcription
factor, Myc-associated zinc ﬁnger protein (MAZ), that
binds to the double-stranded and G-quadruplex conforma-
tions of the GGA repeat region and represses c-myb
promoter activity. Our ﬁndings suggest that the c-myb
G-quadruplexes act as anegative regulator of the promoter
and that MAZ may repress c-myb promoter activity by
binding to the c-myb T:H:H:T G-quadruplexes.
MATERIALS AND METHODS
Oligonucleotides
The oligonucleotide (ODN) containing the pyrazolopyri-
midine analog of guanine (PPG) was synthesized by
Murine:  3′ -AGGAGGAGGAGGAAGAGGAGG AAGAGGAGGAGGAGGAG .............
Rat:  3′ -AGGAGGAGGAGGAAGAGGAGG AAGAGGAGGAGGAGGAG .............
Dog:  3′ -AGGAGGAGGAGGAAGAGGAGGAGGAGGCGCTGGAGGAGGAGG
Domestic:  3′ -AGGAGGAGGAGGAAGAGGAGGAGGAGGCGCTGGAGGAGGAGG
Cow 
A
B
(GGA)8 2(GGA)4
′
′
Figure 1. The c-myb promoter and key transcription factors that regulate c-myb expression and T:H:H:T G-quadruplexes formed by 2(GGA)4 or
(GGA)8 (19–22). (A) Transcription initiation site (+1) is indicated with an arrow. Inhibitors: c-Myb ( 596  618), WT1 ( 390  428), myeloid
zinc ﬁnger 1 (MZF-1,  50  64 and  162  178) and PU.1 binding site (+15 +20). Activators: Ets ( 251  270) and c-Jun/JunD
( 138  162). Putative transcription factors that bind to the GGA repeat region include MAZ, RXR and VDR, which have multiple binding sites
in the GGA repeat region. The myb GGA repeat sequences in diﬀerent species are compared, and R1 and R3 are most conserved in the ﬁve diﬀerent
species. (B) Left: (GGA)4 forms a T:H and two T:Hs intermolecularly dimerize to form a T:H:H:T G-quadruplex (taken from reference 19). Right:
(GGA)8 forms two T:Hs that dimerize intramolecularly, resulting in a T:H:H:T G-quadruplex (modiﬁed from reference 21).
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ODNs were synthesized by Operon Biotechnologies, Inc.
(Huntsville, AL, USA). ODNs were gel puriﬁed and the
concentrations were determined by using a spectropho-
tometer. A summary and sequences of the ODNs are
shown in Table 1 and Supplementary Data, respectively.
Circular dichroism spectroscopy
ODNs for circular dichroism (CD) were prepared at 5 or
1.25mM in 50mM Tris-HCl (pH 7.5) in the presence or
absence of 140mM KCl. Samples were denatured at 958C
and slowly cooled to room temperature. CD spectra were
measured by a Jasco-810 spectropolarimeter (Jasco,
Easton, MD, USA) using a quartz cell of 1-mm optical
path length, an instrument scanning speed of 100nm/min,
with a response of 1s, over a range of 200–350nm. A set
of three scans was averaged for each sample at 258C.
Dimethylsulfate protectionassay
ODNs were 50-end labeled, diluted to 100nM in 40mlo f
10mM Tris-HCl (pH 8.0), denatured at 958C, and slowly
cooled down to 378C in the presence or absence of
140mM KCl. An amount of 1mg of dIdC was added to
each sample, and the sample was treated with 0.5%
dimethylsulfate (DMS) as a ﬁnal concentration for 5min
at RT. The reaction was quenched by adding 50mlo fa
stop solution (1.5M sodium acetate (pH 7.0), 1M
b-mercaptoethanol, 250mg/ml yeast tRNA), and the
DMS-treated ODNs were cleaved by 10%(v/v) piperidine,
and separated on a 10% sequencing gel.
Polymerase arrest assays
DNA-polymerase arrest assays were performed as pre-
viously described (25). Brieﬂy, a primer was annealed to
the template bearing the sequence of interest and gel
puriﬁed. The asymmetric primer-template duplex was
incubated in the absence or presence of 140mM KCl at
378C overnight, and primer extension was conducted with
Taq polymerase (Fermentas, Hanover, MD, USA) at
478C for 20min.
RNA polymerase arrest assays were conducted by using
the in vitro transcription kit T7 MEGAshortscript from
Ambion (Austin, TX, USA) according to the manufac-
turer’s protocol. The top sequence of T7 promoter was
annealed to template ODNs bearing the bottom sequence
of T7 promoter followed by the c-myb GGA repeat
region. In vitro transcription from the T7 promoter site
was conducted in the presence of rNTPs and
32P alpha
UTP for 2h at 378C. The reaction was stopped by
digesting DNA templates with DNase I, and the transcrip-
tion products were separated on a 12% denaturing gel.
Celllines
The T-cell acute lymphoblastic leukemia cell line CCRF-
CEM was purchased from ATCC (Manassas, VA, USA);
the chronic myelogenous leukemia (CML) cell line K562
was purchased from Coriell Cell Repositories (Camden,
NJ, USA); and the genetically modiﬁed human embryonic
kidney cell line Flp-In
TM 293 was purchased from
Invitrogen (Carlsbad, CA, USA). Cell lines were main-
tained as recommended by the suppliers.
Site-directed mutagenesis
The wild-type c-myb reporter plasmid pMybWT was
constructed by subcloning the 900bp c-myb promoter in
the plasmid LB178 into a pGL3 basic vector (Promega,
Madison, WI, USA). All the mutant c-myb reporter
plasmids, except for pMybDelR2, were generated by using
the QuikChange XL Site-Directed Mutagenesis Kit
(Stratagene, La Jolla, CA, USA) according to the
manufacturer’s protocol. For pMybDelR2, mutagenic
PCR ampliﬁed the reporter plasmid pMybWT excluding
Region 2 GGA repeats in the promoter, and then the PCR
product was ligated in order to circularize it. The c-myb
GGA repeat region and adjacent ﬂanking region in the
reporter plasmids were sequenced in order to conﬁrm that
there were no unintended mutations introduced during
mutagenesis.
Generationof Flp-In 293 MybWTluciferase reporter
stablecells
The c-myb reporter plasmid pFRT/MybWT/Luc for
stable transfection was generated by cloning the BglII/
XbaI fragment containing the wild-type myb promoter
Table 1. Summary of ODNs used in this study
DMS protection CD spectra EMSA DNA pol arrest RNA pol arrest
c-Myb GGA repeat region Wildtype I XI XXI
R1 mut II XII
R2 mut III XIII
R3 mut IV XIV
(GGA)8 control V V XVII
R1 and 2 VI VI
PPG R1 and 2 VII VII
R1 duplex VIII
R2 duplex IX
R3 duplex X
R2 and 3 XV XXV
R3 XVI XXVI
For sequence details, see Supplementary Data.
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construct at the BglII and SpeI sites of a pcDNA5/FRT
vector, in which the CMV promoter of the vector has been
deleted (Invitrogen, Carlsbad, CA, USA). The sequence of
the insert was conﬁrmed by sequencing.
The Flp-In 293 MybWT reporter stable cell line was
generated by following the manufacturer’s protocol.
Brieﬂy, the pFRT/MybWT/Luc construct and pOG44at
a ratio of 1:9 were transfected into the Flp-in 293 cells
(Invitrogen, Carlsbad, CA, USA) by using ExGen500
(Fermentas, Glen Burnie, MD, USA) according to the
company’s protocol. Transfected cells were selected and
maintained with hygromycin at 150mg/ml in DMEM
(Cellgro, Herndon, VA, USA). After the selection, stable
transfectants were pooled and expanded for use in
experiments. Successful integration of the reporter con-
struct at the ﬂp recombinase target was inferred from the
phenotype of the cells (gain of hygromycin resistance, loss
of Zeocin resistance and gain of luciferase expression).
Transient transfection and luciferase assay
CCRF-CEM cells in exponential growth phase were
plated at a density of 6 10
5 cells/well of a 24-well plate
in 500ml OPTI MEM (Invitrogen, Carlsbad, CA, USA).
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) was
used as a transfection reagent, and transient transfection
was conducted according to the manufacturer’s protocol,
using 10ng of the renilla luciferase reporter plasmid pRL
SV40 and 1mg of the c-myb reporter plasmids. Fireﬂy and
renilla luciferase activities were measured by using a dual
luciferase reporter assay system (Promega, Madison, WI,
USA) 24h after transfection. Relative luciferase activities
were acquired by normalizing the ratio of the ﬁreﬂy
luciferase activity to the renilla luciferase activity of the
mutant construct with that of the wild-type construct.
Each transfection of the c-myb report plasmids was done
in duplicate, repeated at least three times. Flp-In 293
stable cells were plated at 50% conﬂuency in a complete
medium, and 0–1.2mg of the FLAG-tagged-MAZ expres-
sion plasmid BRB112 were transfected by using
Lipofectamine 2000. Twenty-four hours after transfection,
cells were lysed and luciferase activities were measured.
Since luciferases in Flp-In 293 stable cells are stably
expressed, total protein amount in the lysate was used to
normalize luciferase activity of the samples. Each trans-
fection of the c-myb reporter plasmids was done in
triplicate, repeated at least three times. The data are
presented as the average relative luciferase activity
compared to the wild-type c-myb promoter from six
luciferase assays per plasmid.
Nuclear extract preparation
K562 cells were harvested, resuspended in RSB buﬀer
(10mM NaCl, 3mM MgCl2, 10mM Tris-HCl, pH 7.5,
0.05% NP-40 and protease inhibitors), vortexed, incu-
bated on ice and spun down. The pellet was washed once
with RSB buﬀer and resuspended in RIPA buﬀer (50mM
Tris-HCl (pH 7.5), 1% NP-40, 0.25% sodium deoxycho-
late, 150mM NaCl, 1mM EDTA and protease inhibi-
tors). Then, samples were vortexed, incubated on ice and
spun down. The supernatant containing nuclear proteins
was stored at  808C.
Expression ofFLAG-MAZ
FLAG-tagged-MAZ was expressed from the plasmid
BRB112 in BL21 (DE3) pLysS cells (Invitrogen, Cedar
Creek, TX, USA) according to the manufacturer’s
protocol. Brieﬂy, BRB112 was transformed into BL21
(DE3) pLysS cells. Overnight culture was prepared from a
single colony and diluted to 1:100 in fresh Luria-Bertani
broth with 0.4% glucose. Pre- and post-induction incuba-
tions were 2h each at 378C, and 1mM of IPTG was used
for induction of FLAG-MAZ expression. After induction,
bacterial cells were harvested and lysed, and FLAG-MAZ
was puriﬁed by a FLAG aﬃnity column according to the
manufacturer’s protocol (Sigma-Aldrich, St Louis, MO,
USA). MAZ was also synthesized by using the TnT
coupled Reticulocyte lysate systems according to the
manufacture’s protocol (Promega, Madison, WI, USA).
Brieﬂy, 2mg of the plasmid BRB112 was used as a DNA
template in a ﬁnal volume of 50ml, and coupled
transcription/translation reaction was conducted at 308C
for 90min.
Electrophoretic mobility shiftassay(EMSA)
and competition EMSA
For EMSA with puriﬁed FLAG-MAZ, 1mg of puriﬁed
FLAG-MAZ was incubated in a binding buﬀer (10mM
Tris-HCl (pH 7.5), 50mM NaCl, 1mM dithiothreitol
(DDT), 1mM EDTA (pH 8.0) and 5% glycerol) in the
presence of 0.2pmol of labeled, double-stranded probes
and incubated for 20min at room temperature. For
EMSA with MAZ synthesized by the TnT coupled
Reticulocyte lysate system, the previously described
methods in (26) were followed. A total of 10mlo f
reticulocyte lysate containing newly synthesized MAZ
was used per sample in the presence of the labeled probes
at 12.5nM. For competition EMSAs, 5mg of K562
nuclear extract was incubated with 0, 5 and 20pmol of
double-stranded cold competitors in the binding buﬀer
with 1mg of dIdC for 20min at room temperature, and
then 0.2pmol of the labeled probes were added to the
reaction and incubated for 20min at room temperature.
Probe-protein complexes were separated on a 4% non-
denaturing gel with 2.4% glycerol in 0.25X TBE at 48C.
DNase I protectionassay
A 260bp GGA repeat region probe was prepared by
digesting pMybWT with BanII and SfcI and labeling by
Klenow ﬁlling. Approximately 18000cpm of the probe
was incubated in a binding buﬀer (25mM Tris-HCl
(pH 8.0), 50mM KCl, 6.25mM MgCl2, 0.5mM EDTA
(pH 8.0), 10% glycerol, 0.5mM DTT) for 10min on ice
in the presence of FLAG peptides, or FLAG-MAZ.
After adding CaCl2 and MgCl2 to 2.5mM and 5mM as
ﬁnal concentrations, respectively, 0.01u of DNase I
(Invitrogen, Carlsbad, CA, USA) was added to each
sample and incubated 2min at room temperature. DNase
I reaction was quenched by adding a stop solution
(100mM NaCl, 15mM EDTA, 0.5% SDS, 50mg/ml
1758 Nucleic Acids Research, 2008, Vol. 36, No. 6yeast tRNA as ﬁnal concentrations). The labeled probes
were recovered via phenol/chloroform extraction followed
by ethanol precipitation and separated on a 6% denatur-
ing gel.
Statistical analysis
Microsoft Excel was used to perform statistical analysis.
Unpaired, two-tailed t-tests were used to determine
statistical diﬀerences in relative luciferase activities of the
wild-type and mutant c-myb reporter constructs, and a
value of P<0.01 was considered signiﬁcant.
RESULTS
The c-myb GGA repeat region forms T:H:H:T
G-quadruplexes
ODNs with the sequence (GGA)4 have been shown to form
a secondary structure composed of a guanine tetrad
stacked on a guanine-adenine heptad. Two tetrad:heptad
(T:H) G-quadruplexes can dimerize by stacking interac-
tions on their heptad planes to form a T:H:H:T structure
(Figure 1B, left, taken from reference 19) (19,20). This
T:H:H:T G-quadruplex can be derived intramolecularlly
from a (GGA)8 ODN and was shown to be very stable,
producing a melting temperature of 868C (22). In this
structure, the two T:H G-quadruplex-forming core
sequences, GGAGGAGGAGG, are linked by a single
adenine nucleotide that does not form any hydrogen bonds
to stabilize the T:H:H:T higher order structure (Figure 1B,
right, modiﬁed from reference 21) (21,22).
Since the c-myb promoter contains three nearly perfect
tandem (GGA)4 repeats (Figure 1A), we speculated that
each could be considered a T:H-forming unit and would
form T:H:H:T structures with slightly longer linker
sequences than in the previously characterized (GGA)8
ODN (Figure 1B, right, modiﬁed from reference 21). We
performed DMS footprinting studies with an ODN
containing all three GGA repeat regions (ODN I) and
ODNs in which each region was mutated to (GCA)4 to
prevent secondary structure formation (ODNs II, III and
IV) (Figure 2A). These studies show potassium-dependent
partial and complete DMS footprints in R1 and R2 in
ODN I, respectively, and in the two unaltered GGA
repeat regions of ODNs II, III and IV (Figure 2A). This
pattern of DMS protection suggests that T:H:H:T
structures are formed within the c-myb GGA repeats,
and further suggests that any two of the three (GGA)4
repeats, such as R2/R3 of ODN II, R1/R3 of ODN III
and R1/R2 of ODN IV, can form the dimer structure,
implying that there is a possible competition for dimeriza-
tion among the three GGA repeat regions. Signiﬁcantly,
R1/R3 in ODN III and R1/R2 in ODNs I and IV form a
strong T:H:H:T dimer and R2/R3 in ODN II forms a less
stable T:H:H:T. Stronger protection of R1 in ODN I
compared to ODN III is probably explained by competi-
tion for dimerization partners in ODN I, where three
T:H:H:T structures (R1/R2, R1/R3 and R2/R3) can
potentially form and probably exist in equilibrium. We
found that the R1 and R3 GGA repeat sequences are
perfectly conserved across multiple mammalian species,
including mice, rats, dogs, cows and humans (Figure 1A),
suggesting that R1 and R3 are evolutionarily conserved to
preserve a DNA secondary structure that controls myb
expression.
CD has been used to deduce the relative orient-
ation (parallel vs antiparallel) of DNA strands in
G-quadruplexes (27), and most forms of G-quadruplexes
produce very characteristic CD spectra. The CD spectrum
of a T:H:H:T from a (GGA)8 oligonucleotide (ODN V) is
shown in Figure 2B, and essentially reproduces the CD
signature for the T:H:H:T structure that was reported in
correlation with the NMR studies from which the
T:H:H:T was identiﬁed (22). ODN VI is an ODN
representing the c-myb promoter and containing GGA
repeat regions 1 and 2 with the ﬂanking sequence and
intervening sequence between the GGA repeats derived
from the c-myb promoter. ODN VI produces the
characteristic CD signature of a T:H:H:T with a strong
peak at 264nm in the presence of potassium, indicating
T:H:H:T G-quadruplex formation by the ODN. In
order to verify that the CD signature of ODN VI is
due to G-quadruplex formation by the ODN, we
tested a negative control oligonucleotide (ODN VII)
with 7-deazaguanine analog substitutions to prevent
G-quadruplex formation. PPG is a pyrazolopyrimidine
analog of guanine in which the N7 and C8 atoms of
guanine are interposed. N7-dependent secondary DNA
structures, such as G-quadruplexes, are usually not
formed, but the PPG retains the same electron density in
the ring system as guanine, and PPG substitutions do not
alter the optical activity (absorption of UV light)
compared to the unfolded form of the guanine oligo. As
shown in Figure 2B, the PPG-substituted oligonucleotide
ODN VII did not produce the CD signature of a T:H:H:T,
conﬁrming that the CD signature of ODN VI is due to
T:H:H:T formation. ODNs I through IV also produce CD
spectra characteristic of a T:H:H:T G-quadruplex in a
potassium-dependent manner (Figure 2C). The T:H:H:T
stability inferred from the signature peaks agrees with the
DMS footprinting results, showing the lowest signature
peak on ODN II and high peaks on ODNs III and IV.
When taken together with the other biochemical studies
presented here, the CD spectra provide strong supporting
evidence for the formation of a T:H:H:T structure by the
GGA repeat regions of the c-myb promoter.
DNA and RNA polymerase stop assays have been used
as a means to show the relative stability of DNA
secondary structure formation in a DNA template
strand and to deduce the location and stability of G-
quadruplexes in single-stranded templates and plasmid
DNA (28,29). Because the GGA repeat region of c-myb
occurs on the transcribed strand downstream of the
transcription start site, RNA polymerase arrest could
occur in the c-myb promoter if a stable G-quadruplex
structure was formed. Thus, both DNA and RNA
polymerase arrest sites at these sequences are potentially
relevant to the disruption of enzymatic function that could
be encountered in cells by G-quadruplex formation in the
c-myb GGA repeat region. The results show that DNA
polymerase (Figure 3A and B) and RNA polymerase
Nucleic Acids Research, 2008, Vol. 36, No. 6 1759(Figure 3C) arrest sites (designated S1 and S2) are
observed precisely at the beginning of the third and
second GGA repeat regions in a potassium-dependent
manner. These results are explained by the polymerase
arrest at S1 from T:H:H:T by the R2/R3 and/or R1/R3
regions and the arrest at S2 by the R1/R2 GGA repeat
regions. The presence of two arrest sites indicates that the
c-myb promoter can form a mixture of stable secondary
structures due to the competition between GGA repeat
regions. In addition, our DMS footprinting data showing
DMS cleavage in both R1 and R3 regions of ODN I
(Figure 2A) support our conclusion that there is an
equilibrium between R1/R2 and R2/R3 that results in
polymerase arrest at S2 and S1, respectively. Furthermore,
our ﬁndings imply that polymerase was not arrested by a
T:H, because otherwise there would be an arrest site
before R1. Signiﬁcantly, in the full-length (FL) c-myb
GGA repeat templates (ODNs XI and XXI), polymerase
A B
ODN V
5′- GGAGGAGGAGGAGGAGGAGGAGGA
ODN VI
5′- AAAGAGGAGGAGGAGGTCACGGAGGAGGAGGAAACAG
ODN VII
5′- AAAGAPPAPPAPPAPPTCACPPAPPAPPAPPAAACAG
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Figure 2. DMS protection assay and CD spectra. (A) DMS methylation patterns are indicated by open circles (methylated), half-shaded circles
(partially methylated) and full-shaded circles (unmethylated). The wild-type GGA repeat sequence (ODN I) shows protection from DMS methylation
in R1 and R2 in the presence of potassium. The (GGA)4 to (GCA)4 mutants (ODNs II, III and IV) show protection in the two intact (GGA)4
repeats in the presence of potassium. Note that Ps in ODN VII means PPGs. (B) Circular dichroism spectra of ODNs V, VI and VII in the presence
of KCl. ODNs V and VI show CD signature of G-quadruplex but not ODN VII. (C) CD spectra of ODNs I, II, III and IV. ODN II shows the
lowest G-quadruplex signature peak and ODNs III and IV show a high signature peak.
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Figure 3. RNA and DNA polymerase arrest assays. (A) The wild-type and regional mutants of the c-myb GGA repeat region show potassium-
dependent Taq polymerase arrest sites. The wild-type GGA repeat sequence (ODN XI) causes two arrest sites before R3 and R2, and the regional
mutants show a single arrest site before the ﬁrst intact (GGA)4. These bands were quantiﬁed by densitometry, and the percentage of arrest products
is shown in the right panel of A. Note that the regions mutated from (GGA)4 to (GCA)4 are indicated as gray ovals. S, S1, and S2 are DNA pol stop
arrest sites. B and C. DNA (B) and RNA (C) polymerase arrest assays with the regional deletion mutants of the c-myb GGA repeat region. Deletion
of R1 (ODNs XV and XXV) result in a single arrest site at S1. Deletion of R1 and R2 (ODNs XVI and XXVI) arrests RNA polymerase at S1 but
not DNA polymerase. The location of the arrest sites (S1 and S2) are shown schematically relative to GGA repeat regions (R1, R2 and R3), the
primer binding site (P), and the FL extension product in the diagram adjacent to the autoradiogram.
Nucleic Acids Research, 2008, Vol. 36, No. 6 1761arrest at the ﬁrst arrest site (S1) is only partial, and the
second arrest site (S2) is more pronounced, consistent with
the data from the DMS protection assays that the
T:H:H:T formed between GGA repeat regions 1 and 2 is
the most preferred, when all three regions are intact.
When one of the GGA repeat regions is mutated (ODNs
XII, XIII and XIV in Figure 3A), T:H:H:T formation
occurs with the two intact GGA repeats and results in a
single arrest site at either S1 or S2. This observation is
comparable to the single arrest site (S) that is observed
before the GGA repeats in a template containing the
(GGA)8 sequence (ODN XVII in Figure 3B) that was used
as a positive control for the T:H:H:T structure (22), and
indicates that any two (GGA)4repeats can form aT:H:H:T
regardless of their positions in the c-myb GGA repeat
region. Of note, although any two (GGA)4 motifs are able
to form a T:H:H:T, the relative amount of arrest product
compared to FL primer extension products varies in ODNs
XI, XII, XIII and XIV, which provides an estimate of the
stability of the T:H:H:T structures formed by the GGA
repeat sequences. For example, in Figure 3A, the arrest
products at S1 and S2 are substantial compared to the
amount of the FL primer extension product in ODN XI
(representing the WT myb sequence), whereas the arrest
product at S1 in ODN XII is only partial compared to the
FL extension product. Our DMS protection assay data
(Figure 2A) and the percentage of arrest products
(Figure 3A) demonstrate that mutation of GGA repeat
region1leadstoaweakT:H:H:Tstructureformedbetween
R2 and R3.
Deletion studies in DNA and RNA polymerase arrest
assays demonstrated that dimerization of two T:H
G-quadruplexes is required for stable quadruplex forma-
tion. When one of the GGA repeat regions is deleted
(ODNs XV and XXV in Figure 3B and C), T:H:H:T
formation takes place by dimerization of two T:H
quadruplexes and causes a single arrest site in both
DNA and RNA polymerase assays. However, when two
GGA repeat regions are deleted (ODNs XVI and XXVI),
a single T:H structure could form, and this structure
partially arrests RNA polymerase (Figure 3C) but not
DNA polymerase (Figure 3B), suggesting that the T:H
structure is not as stable as the T:H:H:T structure, in
support of the concept that stacking interactions between
the heptad planes of two T:H subunits lead to a more
stable higher order T:H:H:T structure.
In summary, these biochemical assays demonstrate that
two (GGA)4 motifs from the c-myb promoter can form a
stable potassium-dependent secondary DNA structure
capable of arresting the progress of DNA and RNA
polymerases and provide evidence for the formation of a
T:H:H:T structure by the c-myb promoter.
The c-myb GGA repeat region plays acritical role in
c-myb promoter activity
In order to investigate the role of the GGA repeat region in
c-myb promoter activity, we performed luciferase assays
using wild-type and mutant c-myb promoters. The reporter
plasmid pMybWT bears the wild-type c-myb promoter
from  719 to +200 with the three intact GGA repeat
regions. The mutant reporter plasmids pMybDelR1,
pMybDelR2 and pMybDelR3 are deletion mutants in
which a (GGA)4 motif has been individually deleted as
shown in Figure 4. We also generated serial deletion
mutant plasmids, pMybDelR1/2 and pMybDelR1/2/3, in
which two or all three GGA repeat regions have been
deleted.Figure4showsrelativeﬁreﬂyluciferaseactivitiesin
CCRF-CEMcellsnormalizedbyrenillaluciferaseactivities
in a dual luciferase assay system. Deletion of GGA repeat
region 1 or both regions 1 and 2 in the c-myb promoter
increased relative luciferase activities by 3- to 5-fold. In
ODNs representing the wild-type c-myb sequence, R1 and
R2 were the two GGA repeat regions involved in T:H:H:T
formation, and deletion of R1 or R1/2 was shown to result
in an unstable secondary structure with the remaining
region(s). In contrast, deletion of R2 has no signiﬁcant
eﬀect on c-myb expression. In ODNs, mutation of R2
resulted in a stable T:H:H:T between R1 and R3. Taken
together, these results support the conclusion that stable
T:H:H:T formation involving two GGA repeat regions
represses c-myb expression. The deletion of region 3 also
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Figure 4. Luciferase activity driven by the wild-type and GGA-deleted c-myb promoters in CCRF-CEM cells. Various c-myb promoters were
transiently transfected into CCRF-CEM cells. Deletion of R1, R3, or both R1 and R2 from the c-myb promoter increases luciferase activity in
CCRT-CEM cells. The R1, R2 and R3 deletion mutant pMybDelR1/2/3 markedly reduces luciferase activity.
 P<0.01
1762 Nucleic Acids Research, 2008, Vol. 36, No. 6signiﬁcantly increased c-myb promoter activity, even
though corresponding mutations in R3 in ODNs repre-
senting the c-myb promoter resulted in a stable T:H:H:T
between R1/R2. The eﬀect of deleting R3 may be explained
by the newly created transcription factor binding site that
is introduced as a result of deletion of R3 and then
subsequent rejoining. We found such a transcription
factor binding site in pMybDelR3, ILF1 (winged-helix
transcriptionfactorIL-2enhancerbindingfactor),byusing
the computer program MatInspector from GenoMatix
(www.genomatix.de). ILF1 is constitutively expressed and
serves as a transcriptional activator of the IL-2 promoter in
the T-cell leukemia cell line Jurkat (30). Since the cell line
CCRF-CEM usedinthis studyisaT-cellleukemia cell line,
it is possible that the ILF1 site created in the GGA repeat
region of pMybDelR3 may act as a transcriptional
activator, which would result in an increase of promoter
activity of pMybDelR3. We also examined the sequence of
pMybDelR1 and pMybDelR1/2 to see if there are any
transcription sites created as a result of deletion of R1 or
both R1 and R2. However, MatInspector did not ﬁnd any
newly introduced transcription sites due to the deletion.
There are transcription factor binding sites that have been
lost in the deletion mutant constructs pMybDelR1,
pMybDelR2andpMybDelR1/2.Nevertheless,considering
luciferase activity of pMybDelR1/2/3, the loss of transcrip-
tionfactorbindingsitesdoesnotseemtocauseanincreased
promoter activity.
Although deletion of R1/2 and R3 individually increased
c-myb promoter activity, the additional 15bp deletion
of region 3 from pMybDelR1/2, which results in complete
removal of all the GGA repeats from the c-myb promoter,
showed almost complete loss of luciferase activity
in CCRF-CEM cells that ranges only 1–3% of the
pMybWT construct. It is important to note that luciferase
activity was still measurable ( 50-fold over background)
from the pMybDelR1/2/3 plasmids. A very low level of
c-myb expression in response to deletion of the entire GGA
repeat region was also observed in two other leukemia cell
lines, Jurkat and K562 (data not shown). Because of the
striking loss of promoter activity by deletion of the GGA
repeats in three cell lines tested, another pMybDelR1/2/3
construct was tested to control for spurious eﬀects from
site-directed mutagenesis, and these results were conﬁrmed
with a second construct plasmid. At least one (GGA)4
repeat region is required for c-myb promoter activity, and
we speculate that duplication of the (GGA)4 motif is used
by the myb promoter to ﬁnely tune c-myb expression by
equilibrium between secondary structure formation and
transcription factor binding to double-stranded DNA.
Collectively, these data show that the c-myb GGA repeats
arecriticalforregulatingc-mybexpressionandsuggestthat
T:H:H:T secondary DNA structures formed by adjacent
(GGA)4 motifs are likely negative regulators of the c-myb
promoter.
The transcription factor MAZbinds to thec-myb GGA
repeat region
Since our data demonstrated that the c-myb GGA repeat
region is a critical cis element for controlling c-myb
promoter activity, we investigated the possible
protein:DNA interactions in the region. First, we searched
for putative transcription factors for the c-myb GGA
repeat region from +2 to +73 with MatInspector
(Supplementary Data). MAZ, RXR, PU.1 and VDR
were identiﬁed as transcription factors that have multiple
potential binding sites in the GGA repeat region. We
performed EMSAs to evaluate the binding of nuclear
proteins from the leukemia cell line K562 to the myb
GGA repeats in the presence of competitor oligos with the
consensus binding sites for these transcription factors.
Since the sequence of the GGA repeat region is repetitive,
we divided the GGA repeat region into three regions
(VIII, IX and X), each of which includes one of the
(GGA)4 repeat regions (R1, R2 and R3, respectively) for
competition EMSAs (Figure 5B) and forms a stable
duplex with a Tm>648C. In the competition EMSA for
investigating MAZ binding, we ﬁrst incubated K562 cell
nuclear extract with 0, 25X or 100X molar excess of a non-
labeled double-stranded competitor bearing a consensus
MAZ binding site or mutant MAZ binding site, and then
the labeled double-stranded probes ODN VIII, IX and X,
representing the three (GGA)4 regions of the c-myb
promoter, were added to the reaction. The competition
EMSAs in Figure 5B demonstrate that the c-myb GGA
duplex repeat region interacts with multiple nuclear
proteins, but several of the protein:DNA complexes were
eliminated by the MAZ consensus competitor but not the
MAZ mutant competitor. We also used consensus binding
sequences for PU.1, RXR and VDR in competition
EMSAs. These data are summarized in Figure 5C, and
the other competition EMSAs are shown as
Supplementary Data. These data provide preliminary
evidence that MAZ, PU.1, RXR and VDR have one or
more binding sites in the c-myb GGA repeats.
To conﬁrm MAZ binding to the c-myb promoter, we
puriﬁed MAZ protein for EMSAs and DNase I footprint-
ing studies. Figure 6A shows that MAZ binds to all three
duplex probes representing the three GGA repeat regions
of the c-myb promoter and the two MAZ-probe
complexes indicates that MAZ may bind to the duplex
probes as a monomer or a dimer. DNase I digestion was
performed on a 260bp fragment of the c-myb promoter in
the presence of either a negative control FLAG peptide
(Figure 6B, lane 2) or puriﬁed FLAG-MAZ (Figure 6B,
lane 3). Only FLAG-MAZ showed protection from
DNase I digestion spanning the GGA repeat region but
not FLAG peptide, conﬁrming our competition EMSA
data that MAZ has multiple binding sites in the c-myb
GGA repeats.
MAZbinds to theG-quadruplexes formedin thec-myb
GGA repeat region and represses promoter activity
MAZ was reported to bind to the G-quadruplex formed
by the G-rich region of the diabetes susceptibility locus
IDDM2 (26). To test if MAZ can also bind to the
G-quadruplexes formed in the c-myb GGA repeat region,
we performed EMSAs with ODNs folded into T:H:H:T
structures in the presence of MAZ in rabbit reticulocyte
lysate as described in (26). First, we tested ODN VI, which
Nucleic Acids Research, 2008, Vol. 36, No. 6 1763contains c-myb GGA repeat regions 1 and 2 and should
form a more stable T:H:H:T than ODN I due to
the lack of competition for dimerization in ODN VI.
ODN V (perfect (GGA)8 sequence) and ODN VII (PPG-
substituted analog of ODN VI) were studied as positive
and negative controls, respectively. Figure 7A shows a
MAZ protein:DNA interaction that is speciﬁc for the
T:H:H:T structure. The band denoted as the T:H:H:T-
MAZ complex is observed with ODNs V and VI, but not
with ODN VII, the PPG-substituted control, and only in
the presence of MAZ. Non-speciﬁc protein:DNA interac-
tions, presumably from proteins in the reticulocyte lysate,
are seen with all three ODNs in the presence or absence of
MAZ. We also conﬁrmed that MAZ binds to the
G-quadruplex(es) formed by the native c-myb promoter
with all three (GGA)4 repeats (Figure 7B). This result
conﬁrms that MAZ binds to the equilibrium structure(s)
formed when all three GGA repeat regions are present, but
the free probe migrates more slowly than ODNs V, VI and
VII because the ODN is longer (Supplementary Data).
We investigated the role of MAZ in regulation of c-myb
expression via transfection of the MAZ expression
plasmid BRB112 in Flp-In 293 Myb WT reporter stable
cells (Figure 8). These Flp-in 293 cells contain the stably
transfected wild-type c-myb promoter and luciferase
coding sequence in the genome, which are originally
from pMybWT (Figure 8). Forced overexpression of
MAZ decreased the activity of the stably transfected myb
promoter, demonstrating that MAZ is a repressor of the
c-myb promoter. We also treated the same myb stable cells
with a pool of three MAZ siRNAs to evaluate the eﬀect of
MAZ knockdown on c-myb promoter activity. However,
siRNA treatment did not change c-myb promoter activity
(data not shown). It is probably because many other
transcription factors interact with and compete each other
for binding to the c-myb GGA repeat region (Figure 5).
Knocking down MAZ would open more opportunity for
other competitor proteins to bind to the region, which
may result in no net changes in c-myb promoter activity.
Collectively,thisstudypresentstheﬁrstevidencethatthe
c-myb GGA repeat region forms T:H:H:T G-quadruplexes
capable of binding to a transcriptional repressor protein.
The GGA repeat region acts as a repressor of c-myb
expression by folding into a G-quadruplex structure and
recruiting transcriptional repressors such as MAZ, which
are needed for basal transcription.
DISCUSSION
In support of previous NMR studies (19–22), our ﬁndings
from DMS protection, CD and polymerase arrest assays
′
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Figure 5. Competition EMSA with K562 nuclear extract. (A) The DNA probes used for EMSAs are illustrated under the corresponding GGA repeat
sequence. The probes are double stranded, but only the G-rich sequence is shown. (B) The results from competition EMSAs using a MAZ competitor
are shown. The protein:DNA complexes completely or almost completely eliminated by the MAZ competitor are indicated with arrows.
(C) Summary of competition EMSA results. The putative transcription factors shown to interact or not to interact with the c-myb GGA repeat
region in competition EMSAs are listed.
1764 Nucleic Acids Research, 2008, Vol. 36, No. 6show that the GGA repeat region in the c-myb promoter is
the ﬁrst example of a genomic sequence that forms
T:H:H:T G-quadruplex-like structures, involving two
adjacent (GGA)4 repeats. Several G-quadruplex regions
have been identiﬁed in promoters and shown to be critical
for regulation of promoter activity. The G-quadruplexes
formed in the c-myc and Kras promoters inhibit promoter
activity (28,29), whereas the G-quadruplex formed in the
human insulin gene activates the promoter (31), which
suggests that these G-quadruplex structures can alter gene
expression. Our promoter-reporter transfection studies
showed that the c-myb G-quadruplex-forming region is
critical for regulation of c-myb expression and that
the deletion of (GGA)4 motifs that destabilize the
G-quadruplex increase promoter activity. The GGA
repeat region of the c-myb gene is highly conserved
across diﬀerent mammalian species (Figure 1A), and the
R1andR3GGArepeat regionsareabsolutely conserved in
all ﬁve mammalian genomes queried. This ﬁnding implies
that R1 and R3 are critical for regulation of myb
expression, and our ﬁnding that deletion of either R1 or
R3 signiﬁcantly alters c-myb transcription supports this
implication. Conversely, GGA repeat region R2 is not
evolutionarily conserved, and deletion of this region has no
eﬀect on c-myb transcription in our studies. The c-myb
GGA repeat region also contains numerous transcription
factor binding sites in these three GGA repeat regions, and
thec-myb promoter mayregulate its activity byaltering the
stability of T:H:H:Ts via changing dimerization partners.
The mechanism by which G-quadruplexes can be
transcriptional activators or inhibitors is not clear. There
are many studies showing that promoter regions that
support G-quadruplex formation are usually also binding
sites for one or more important transcription factors
(32–36). For instance, the c-myc NHE G-quadruplex-
forming region involves various DNA-binding proteins,
such as the double-strand binding protein Sp1 (32), the
single-strand binding proteins CNBP (33) and hnRNP K
(34), and possibly yet-to-be-discovered proteins that can
recognize the G-quadruplex formed by this sequence.
These protein interactions are probably in ﬁne balance
and competing for potentially complementary or exclusive
binding sites. Interaction with transcription factors
speciﬁc for a certain DNA conformation would shift the
equilibrium to the DNA conformation at the region,
which would be critical for determining promoter activity.
Supporting this model of transcriptional regulation by
recognition of diﬀerent DNA conformations, the ErbB2
Hr-DNA formation in the GGA repeats that is homo-
logous to those in the c-myb promoter displaced the
binding of the critical transcription factor Ets in the
ErbB2 GGA repeat region, conversely, Ets binding
inhibited Hr-DNA formation (37). This observation
suggests that secondary DNA structures and
protein:DNA interactions can inﬂuence each other to
either activate or suppress gene expression. In agreement
with this concept, our EMSA results demonstrate that the
c-myb GGA repeat region actively interacts with many
nuclear proteins (Figure 5) when it is double stranded,
which might mean that T:H:H:T formation downregulates
promoter activity by simply displacing double-strand
binding nuclear proteins.
The c-myb GGA repeat region is a hot spot for nuclear
protein interaction as shown in Figure 5. Several previous
studies showed that GGA repeats in a gene promoter were
critical transcriptional activator binding sites (23,24).
Similarly, our luciferase assay results demonstrated that
the GGA repeat region is essential for c-myb promoter
activity, which is abolished when the GGA repeats are
deleted (Figure 4), probably due to the loss of transcrip-
tion factor binding sites. These results indicate that the
GGA repeat region has to be available for transcriptional
activators to bind to the promoter and may imply that
G-quadruplex formation, if stabilized by a small molecule,
could also markedly inhibit c-myb expression, making the
region unavailable for transcription factor binding. The
discovery and development of small molecule ligands for
G-quadruplexes is the subject of investigation by several
research groups (38,39).
We identiﬁed MAZ as one of the transcription factors
that bind to the GGA repeat region of c-myb, and showed
that MAZ can bind to both double-stranded DNA and
T:H:H:T conformations of the c-myb promoter. MAZ
was ﬁrst identiﬁed as a GA box binding transcription
C
A
G
G
A
G
A
A
A
G
A
5′
A
A
C
A
G
G
T
T
G
A
T
A
G FLAG-MAZ
FLAG pep.
VIII IX X
AB
1 23
Figure 6. Electrophoretic mobility shift and DNase I protection assays
with FLAG-MAZ. (A) EMSA. The complexes of FLAG-MAZ and the
c-myb probes are indicated with arrows. (B) DNase I protection assay.
Lane 1: sequencing for guanines, lane 2: FLAG peptide and lane 3:
FLAG-MAZ. The area protected from DNase I digestion is marked
with a solid line.
Nucleic Acids Research, 2008, Vol. 36, No. 6 1765factor in the c-myc promoter and was shown to control P1
and P2 promoter activities of the c-myc gene (40–43).
MAZ is constitutively expressed in various tissues (44),
but abnormal MAZ expression is found in the terminal
phase of CML, suggesting that overexpression of MAZ
plays a role in the progression of CML (45). The
functional role of MAZ is dependent on the target gene,
and some promoters are activated by MAZ (46–48), while
others are repressed (49,50). One possible explanation for
the dual roles of MAZ may be that diﬀerent cofactors
interact with MAZ depending on the target promoter.
Song et al. (50) showed that MAZ acts as a negative
regulator via physical interaction with HDAC (histone
deacetylase complex), and Jordan-Sciutto et al. demon-
strated that MAZ interacts with FAC1 (Fetal Alzheimer’s
clone 1), a truncation of the chromatin remodeler BPTF
(bromodomain and PHD domain transcription factor)
(51,52). Interestingly, MAZ and the MAZ-like protein
THZif-1 (triple-helix-binding zinc-ﬁnger protein-1) have
now been shown to bind to secondary DNA structures
(26,53). The G-quadruplex structure formed in the
IDDM2 locus, a critical regulator of IDDM2 promoter
activity, is recognized by MAZ; however, MAZ does not
bind to the unfolded form of the G-quadruplex-forming
region (26). Moreover, the MAZ-like protein THZif-1 was
shown to interact with the triplex formed in the c-myc
NHE, which is both crucial for c-myc promoter activity,
and more recently investigated by several groups as
a G-quadruplex forming element (28,53–55). These
observations suggest that regulation of promoter activity
by MAZ and related proteins may involve recognition
of secondary DNA structures. Some proteins, such as
RAP1 (Repressor-activator protein 1), Thrombin and
DNA topoisomerase I, have been shown to stabilize
G-quadruplexes (56–58). Other proteins, including RecQ
helicases, RPA (Replication Protein A) and POT1
(Protection of Telomere 1), may inhibit secondary
structure formation or serve to resolve secondary DNA
structures (59–61). In the case of G-quadruplexes formed
in gene promoters, we propose that these genes are
regulated by mechanisms involving single-stranded,
double-stranded and folded DNA-binding proteins that
may inhibit or promote G-quadruplex formation.
Furthermore, it is possible that some proteins can bind
to more than one DNA conformations, as we have shown
with MAZ in this study (Figures 6 and 7). Since MAZ has
dual binding activities to both double-stranded and
G-quadruplex DNA, regulation of promoter activity by
MAZ might be determined by the cofactors that interact
with MAZ. It is not known how MAZ recruits diﬀerent
cofactors, but it may depend on levels of MAZ in the
nucleus or on posttranslational modiﬁcations, such as
phosphorylation of MAZ. It is also possible that MAZ
binding to double-stranded or G-quadruplex DNA could
result in changes in available transactivation domains of
MAZ, which may allow diﬀerent groups of transcription
factors to interact with MAZ to determine its role.
Moreover, the c-myb GGA repeat region is the ﬁrst
identiﬁed G-quadruplex-forming element in a transcribed
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Figure 8. Transfection of the MAZ expression plasmid BRB112 into
the Flp-In 293 Myb WT reporter stable cells. 0–1.2mg of BRB112 were
transfected into the Flp-In 293 Myb WT reporter stable cells and
luciferase activities were measured 24h after transfection. MAZ
overexpression resulted in inhibition of c-myb promoter activity.
 P<0.01.
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Figure 7. MAZ binding to the G-quadruplexes formed by GGA repeat DNA. (A) EMSA with ODNs V, VI and VII in the presence or absence of
MAZ in rabbit reticulocyte lysate. MAZ in rabbit reticulocyte lysate binds to the T:H:H:T G-quadruplexes formed in ODNs V and VI but does not
bind to the ODN VII that cannot form a G-quadruplex. DNA-protein complexes formed with MAZ or nonspeciﬁc lysate protein and the probes are
indicated with arrows. (B) EMSA with ODNs V and I. ODN V, a positive control for MAZ binding to a T:H:H:T, conﬁrms that MAZ also binds to
the wild-type c-myb GGA repeat sequence ODN I. Due to the diﬀerent size of ODNs I and V, the free probes show diﬀerent mobility.
1766 Nucleic Acids Research, 2008, Vol. 36, No. 6region that indicates that T:H:H:T formation in the c-myb
promoter may play a role as a transcriptional repressor
not only by changing transcription factor interaction
but also by acting as a roadblock to transcriptional
machinery. Forced overexpression of MAZ dramatically
downregulates c-myb promoter activity (Figure 8),
indicating that MAZ is a transcriptional repressor of the
c-myb promoter. However, these data do not show
whether repression of c-myb expression is due to MAZ
binding to duplex DNA or to the T:H:H:T structure.
The c-myb GGA repeat region is very complex,
involving DNA conformational changes from double-
stranded to G-quadruplex forms that subsequently alter
transcription factor binding to the region. In spite of this
complexity, we have shown here the importance of the
T:H:H:T G-quadruplex-forming region of the c-myb
promoter in controlling promoter activity, identiﬁed
MAZ as a T:H:H:T binding transcription factor, and
presented preliminary evidence that MAZ is a repressor of
the c-myb promoter. Further study is needed to discrimi-
nate DNA conformation–dependent roles for MAZ in
regulation of the c-myb promoter, to identify the cofactors
that bind to MAZ depending on DNA structure, and to
elucidate what determines MAZ binding to either
G-quadruplex or double-stranded DNA.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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